Produits pharmaceutiques de la chaîne du froid: 2025 Tendances & Meilleures pratiques
Mis à jour en novembre 20, 2025 Cold chain pharmaceuticals refer to temperaturecontrolled drugs and biologics that must be kept within strict ranges during manufacture, stockage et distribution. The global cold chain industry is projected to reach US$393–453 billion in 2025 and scale to US$1.63 trillion by 2035. This growth is powered by surging demand for biologics, gene therapies and weightloss drugs that require refrigerated or ultracold storage. In this article you’ll learn how to prepare for this evolving market, why technology and sustainability matter, and what practical steps you can take now. Facteurs de demande: how biologics, cell and gene therapies and changing disease patterns increase cold chain requirements. Innovations technologiques: Capteurs IoT, robotique, AI and smart packaging that enable realtime visibility and reduce waste. Pressions réglementaires et de durabilité: why new rules and carbon reduction goals are reshaping temperaturecontrolled logistics. Conseils pratiques: actions you can take to improve compliance, reduce risk and build resilience, including a selfassessment tool. What Drives the Surging Demand for Cold Chain Pharmaceuticals? Rising global demand for temperaturesensitive...